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Abstract
Background: The unpredictable nature of the potentially devastating impact of 2009 pH1N1 influenza pandemic
highlights the need for pandemic preparedness planning, where modeling studies could be most useful for
simulations of possible future scenarios.
Methods: A compartmental model with pre-symptomatic and asymptomatic influenza infections is proposed
which incorporates age groups as well as intervention measures such as age-specific vaccination, in order to study
spread of influenza in a community.
Results: We derive the basic reproduction number and other effective reproduction numbers under various
intervention measures. For illustration, we make use of the Pneumonia and Influenza (P&I) mortality data and
vaccination data of the very young (age 0-2) and the very old (age >64) during 2004-2005 Taiwan winter influenza
season to fit our model and to compute the relevant reproduction numbers. The reproduction number for this
winter flu season is estimated to be slightly above one (~1.0001).
Conclusions: Comparatively large errors in fitting the P&I mortality data of the elderly (>64) were observed shortly
after winter school closings in January, which may indicate the impact of younger, more active age groups
transmitting influenza to other age groups outside of the school settings; in particular, to the elderly in the
households. Pre-symptomatic infections seemed to have little effect on the model fit, while asymptomatic infection
by asymptomatic infectives has a more pronounced impact on the model fit for the elderly mortality, perhaps
indicating a larger role in disease transmission by asymptomatic infection. Simulations indicate that the impact of
vaccination on the disease incidence might not be fully revealed in the change (or the lack thereof) in the
effective reproduction number with interventions, but could still be substantial. The estimated per contact
transmission probability for susceptible elderly is significantly higher than that of any other age group, perhaps
highlighting the vulnerability of the elderly due to close contacts with their caretakers from other age groups. The
relative impact of targeting the very young and the very old for vaccination was weakened by their relative
inactivity, thus giving evidence of the lack of impact of vaccinating these two groups on the overall transmissibility
of the disease in the community. This further underscores the need for morbidity-based strategy to prevent elderly
mortality.
Background
In the spring of 2009, the novel H1N1 influenza virus
first emerged in Mexico and later spread widely
throughout the world within just a few months. The
World Health Organization (WHO) announced on June
11 the start of 2009 influenza pandemic [1], and further
issued an advisory on August 28 for countries in the
northern hemisphere to prepare for a second wave of
pandemic spread in the coming fall/winter [2]. As of
November 8, more than 206 countries and overseas ter-
ritories or communities worldwide have reported labora-
tory confirmed cases of the pandemic pH1N1 virus,
including over 6250 deaths [3].
To lessen the severity of this pandemic, developing an
effective flu vaccine and a global vaccination strategy is
considered to be among the most important medical
interventions [4]. However, to have the greatest impact,
pandemic vaccines need to be available quickly and in
large quantities, and to be delivered to the population
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strain might take up to six months to manufacture and
deliver, even in developed countries [5]. Given the
potential threat of drug-resistance resulting from wide-
spread use of antiviral treatment against pandemic flu,
vaccine appears to be our primary weapon to prevent
and to mitigate a pandemic. However, in addition to the
need to consider the logistics of implementing large-
scale vaccination, distinctly different age-specific mortal-
ities had also been observed during some past flu pan-
demics (e.g., in 1918 [6]), which require different
priorities when large-scale vaccination is to be
implemented.
Moreover, vaccine for influenza is known to have dif-
ferent efficacy (i.e., reduction in the number of infectives)
and effectiveness (i.e., reduction in symptomatic case
number) for different age groups, see e.g., [7-9]. Setting
priority for vaccination by targeting age groups most vul-
nerable (the elderly, infants, etc.) to prevent mortalities is
commonly employed in most countries. However, when
vaccinating those at greatest risk of mortality becomes
impractical (if, e.g., medical care is relatively inaccessible)
or inefficient (if, e.g., immune response is deficient), tar-
g e t i n gt h o s em o s tl i k e l yt oe x p o s et h e mt oi n f e c t i o n
might be more preferable [10]. In this way, the very
young and the old might be better protected by vaccinat-
ing those who are most likely to be in contact with them
(thereby reducing their risk of exposure), rather than by
being vaccinated. Comparison of influenza mortality
among elderly Japanese during time periods when
schoolchildren were and were not vaccinated suggests
that the infected children pose a risk to others [11],
including the elderly. Moreover, several past US experi-
ences (as summarized in [12]) also are consistent with
this conclusion. Nonetheless, influenza policymakers
have typically advocated protecting those individuals of
ages 6-24 months and >65 years directly.
Bansal et al. [13] recently carried out a comparative
analysis of two classes of suggested vaccination strate-
gies, namely, the mortality-based strategies that target
the high-risk populations and the morbidity-based stra-
tegies that target the high-prevalence populations, by
applying the methods of contact network epidemiology
to a model of disease transmission in a large urban
population. Using a range of mortality rates reported
previously for past influenza epidemics and pandemics,
they concluded that the optimal strategy depends criti-
cally on the viral transmission level (or reproduction
number) of the virus. That is, the morbidity-based stra-
tegies outperform the mortality-based strategies for
moderately transmissible strains, while the reverse is
true for highly transmissible strains. However, they also
cautioned that when information pertaining to viral
transmission rate of a particular disease and the
frequency of new introductions into the community
prior to an outbreak is unreliable or not available, a
mortality-based vaccination priority is recommended.
This further demonstrates the importance of targeting
and, moreover, the uncertainty surrounding this issue.
To further the uncertainties regarding influenza pan-
demic preparedness planning, it is widely believed that
asymptomatic cases (i.e., individuals who had been
infected but showed little or no symptoms) and asymp-
tomatic infection of influenza (i.e., infection caused by
an asymptomatic case) do indeed occur regularly (e.g.,
[14-17]).
Model with only asymptomatic infections, by either
asymptomatic or subclinical infectives, during their
infectivity period had been recently studied in [14]. In
this current study, we will consider a traditional com-
partmental model which incorporates both pre-sympto-
matic and asymptomatic infections, in order to explore
the role which they could play in the overall spread of
disease, if any. Moreover, the age-group structure of the
model, by dividing the population into seven groups of
the very young, preschool children, younger and older
schoolchildren, young adults, adults, and the elderly,
allows us to study targeted public health policies (e.g.,
immunization) aimed at different age groups. Our
model also allows for inclusion of immunity and other
age-dependent intervention measures such as quarantine
and voluntary home withdrawal (see e.g., [15,16]). A full
model will be proposed to take into account of the
above-mentioned factors that may be important in
determining the best vaccine strategy.
Methods
Model Formulation
Our model is an age-dependent compartmental model.
The model flowchart is given in Fig. 1, where the sub-
script i denotes the i
th age group. The model variables
are described as follows, with the time unit t in days:
Si(t): number of susceptible individuals of the ith age
group at time t;
Vi(t): number of vaccinated individuals of the ith age
group at time t;
Ei(t): number of exposed (infected) individuals of the
ith age group at time t;
Et i
V () : number of exposed (infected) vaccinated
individuals of the ith age group at time t;
Qi(t): number of quarantined infected individuals of
the ith age group at time t;
Ii(t): number of infective individuals of the ith age
group at time t;
Ii
v(t): number of vaccinated infective individuals of the
ith age group at time t;
Ai(t): number of asymptomatic (subclinical) infective
individuals of the ith age group at time t;
Hsieh BMC Infectious Diseases 2010, 10:106
http://www.biomedcentral.com/1471-2334/10/106
Page 2 of 12Hi(t): number of hospitalized (treated) individuals of
the ith age group at time t;
Zi(t): number of recovered and immune individuals of
the ith age group at time t;
Di(t): cumulative number of influenza deaths of the ith
age group at time t;
cij: contact rate of an individual of ith group with an
individual of jth group;
bij: per contact transmission probability of a suscepti-
ble individual of ith group by an infective of jth group.
πi: age-specific vaccine efficacy for age group i.
li(t) and i
V t (): disease incidence rates for the sus-
ceptible and vaccinated individuals of age group i. See
[Additional file 1] for detailed formulae.
The rest of the model parameters are listed in Tables
1-2, with the age-specific parameters given in Table 2.
The detailed description of the model is given in [Addi-
tional file 1]. Our main model assumptions are as
follows:
(1) Exposed individuals are infective during the incuba-
tion period. It is commonly known (e.g., [18]) that the
pre-symptomatic (exposed) individuals cannot transmit
Figure 1 Model flow diagram.
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which the viral titres gradually increase to detectable and
transmissible levels when they became infective for only
a short period (0.25 days in [19]) before the onset of
symptoms. To avoid adding an extra compartment to
account for the (short) period of infectivity after the end
of the latent period and before the end of incubation per-
iod (see e.g., [20]), we assume that the individuals are
infective during the incubation period with the infectivity
averaged out over the whole incubation period. This sim-
plification is reasonable since the incubation period for
influenza is typically very short, e.g., 1.48 days in [21].
(2) Influenza vaccine is efficacious in preventing influ-
enza infection and effective against influenza-like illness,
albeit at different levels of efficacy and effectiveness for
different age groups [8,9]. Moreover, the vaccinated indi-
viduals are less infectious,o n c et h e yb e c o m ei n f e c t e d ,
when compared to those who had not been vaccinated.
(3) The quarantined individuals will be hospitalized
directly following the onset of symptoms (see [22,23] for
modeling of quarantine for 2003 SARS outbreak).
(4) A fraction of the infectives has no symptoms or
only subclinical symptoms, and is classified as asympto-
matic infectives with reduced infectivity [14].
Table 1 Model parameters with parameter values taken from published literature [15,19,21]. The parameter values
without a source (mostly 0) are assumed values.
Parameter Description Baseline value Source
s mean vaccine waning rate 0
1/g mean incubation period of exposed individuals 1.48 [21]
1/g1 mean time to onset of those who had been quarantined NA
r mean recovery rate of untreated infectives 1/2.85 [19]
r
V mean recovery rate of vaccinated infectives with r
V ≥ r 1/2.85 [19]
r2 mean recovery rate of asymptomatic infectives 1/2.85 [19]
ω mean immune waning rate 0
 migration rate of the population 0
1 migration rate of symptomatic infectives 0
θ immigration rate of the population 0
θ1 immigration rate of symptomatic infectives 0
q quarantine rate of unvaccinated exposed individuals 0
q
V quarantine rate of vaccinated exposed individuals 0
1-j home withdrawal rate of untreated symptomatic infectives 0
1-j1 home withdrawal rate of all “well” individuals 0
τ reduction in infectivity of unvaccinated pre-symptomatic infectives 0.4
τ1 reduction in infectivity of asymptomatic infectives 0.5 [15]
τ2 reduction factor in contact due to hospital isolation 0
 reduction in infectivity of vaccinated infectives 0.5 [15]
Table 2 Age-specific model parameters with the following sources: the age-specific values of vaccine efficacy and
effectiveness [8,9], fraction of the symptomatic infectives [15] and [28], and all other values from 2003-2006 Taiwan
flu monitor surveillance data.
parameter\age group 0-2 3-5 6-7 8-14 15-21 22-64 ≥ 65
time-dependent vaccination rate νi(t) υ1(t) 00000 υ7(t)
vaccine efficacy πi [8,9] 0.7 0.7 0.7 0.7 0.5 0.5 0.4
fraction of asymptomatic infectives ai [15,28] 0.5 0.5 0.5 0.5 0.5 0.5 0.7
reduced fraction of asymptomatic infectives due to vaccination i
V [8,9] 0.4 0.4 0.4 0.4 0.4 0.4 0.6
mortality rate of untreated infectives δi 6×1 0
-4 5×1 0
-4 5×1 0
-5 5×1 0
-5 5×1 0
-5 1×1 0
-4 0.002
mortality rate of untreated vaccinated infectives i
V *6 × 1 0
-4 5×1 0
-4 5×1 0
-5 5×1 0
-5 5×1 0
-5 1×1 0
-4 0.002
mortality rate of hospitalized infectives i 0.006 0.005 5 × 10
-4 5×1 0
-4 5×1 0
-4 0.001 0.02
mean recovery rate of the hospitalized infectives r1 1/4.85 1/4.72 1/4.45 1/4.56 1/5.55 1/9.16 1/16.94
hospitalization rate of unvaccinated symptomatic infectives hi 0.007 0.007 0.007 0.007 0.007 0.007 0.09
hospitalization rate of vaccinated symptomatic infectives hi
V * 0.007 0.007 0.007 0.007 0.007 0.007 0.06
per contact transmission probability of infectees in i
th group bij ≡ bi 0.047 0.039 0.031 0.031 0.047 0.045 0.155
per contact transmission probability of infectors in i
th group bij ≡ bj 0.083 0.029 0.045 0.008 0.040 0.056 0.078
*Note that hi ≥ hi
V and i
V ≤ δi.
The last four rows (in bold) were obtained by least-squared curve-fitting with data using MATLAB software.
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either by death or discharged due to recovery from
illness.
(6) Homogeneous mixing within subpopulations is
assumed.
(7) Negligible births and deaths (excluding disease
deaths) during the course of the disease outbreak are
assumed.
Reproduction Numbers
The basic reproduction number R0, the average number
of infections by an infective in an immunologically naive
population (see, e.g., Diekmann et al. [24] or van den
Driessche and Watmough [25]), is an important epide-
miological quantity which gives indication to the poten-
tial severity of an epidemic. More precisely, the
epidemic cannot be eradicated without interventions if
R0 exceeds unity. Denoting S0i = Si(0), we have
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For illustration, the case n = 2 is described graphically
in Fig. 2, where
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The two blue arrows denotes within-group infections
(R11 and R22) and the black arrows denote inter-group
infection cycle (R12R21). The term R11R22 subtracted in (3)
accounts for the redundancy that resulted when adding R11
and R22. Similar results for the basic reproduction number
of a multi-group model were also obtained in [26,27].
Moreover, we have the following effective reproduc-
tion numbers due to interventions:
(i) The effective reproduction number with interven-
tions excluding vaccination RE is
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i, j = 1, 2, ... , n.
(ii) The effective reproduction number with vaccination
only over a time period of immunization [0, T], RV, is:
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Figure 2 Graphical illustration of the basic reproduction
number for n = 2. The two blue arrows denotes within-group
infections (R11 and R22) and the black arrows denote the inter-group
infection cycle (R12R21). The term R11R22 subtracted in (3) accounts
the redundancy due to adding both R11 and R22.
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Page 5 of 12(iii) The effective reproduction number with interven-
tions including vaccination RVE over the time period [0,
T], is
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Detailed derivations of the reproduction numbers are
also given in [Additional file 1]. Model fit using 2005-
2006 Taiwan winter seasonal influenza data and age-
specific vaccination data as it was implemented during
that flu season, as well as simulation studies of hypothe-
tical scenarios, will be carried out.
Simulations with Taiwan Seasonal Influenza
With the issue of morbidity-based vs. mortality-based
vaccine strategy for pandemic influenza still open to
debate, the Taiwan Centers for Disease Control (TCDC)
launched a new program of free flu vaccination for 1st
and 2nd grades elementary school students (age 6-7)
prior to the 2007-2008 winter flu season which was
expanded further to include grades 1-4 in the fall of
2008. The aim of this vaccine program is hopefully to
lower the seasonal influenza incidence across all age
groups of the population. In anticipation of future inves-
tigation on public health impact of this program, we
carry out model simulations by dividing the Taiwan
population into 7 age groups (see Table 2), and by mak-
ing use of the weekly Taiwan influenza vaccination data
for young children of age 2 or less (age group 1, with
free flu vaccination since 2004) and the elderly of 65 or
older (age group 7, with free flu vaccination since 2001)
during the 2004-2005 winter flu season. The average
vaccine coverages of age groups 1 and 7 during the
2004-2005 winter season in Taiwan are 63.4% and
58.2%, respectively.
There were no other nonpharmaceutical intervention
measures during this winter flu season. That is, all para-
meters pertaining to quarantine and home withdrawal
in the model are set to be 0 in Table 1. Moreover, for
the sake of simplicity, we assume no noticeable level of
migration and no waning of immunity during the flu
season. The rest of the parameter values used are given
in Tables 1-2. We also assume a conservative 20% pre-
epidemic immunity in our simulation based on a recent
sero-epidemiological survey conducted during 2005-
2006 winter flu season in Taiwan [28].
For the contact rates between different age groups, we
make use of the age-specific contact matrix obtained by
Wallinga et al. [29] for Utrecht, the Netherlands, 1986.
We adjust for the discrepancy in the population age dis-
tributions of Taiwan in 2005 and the Netherlands in
1986, by considering the ratios of demographic age
structures of Netherlands in 1987 (Appendix Table 1 in
[29]) and of Taiwan in 2005 [Additional file 1: Table
A1]. The resulting contact matrix, of the average daily
number of contacts for each individual in a certain age
group with individuals in another age group, is given in
[Additional file 1: Table A2].
Fitting with Seasonal Influenza Data
The age-dependent hospitalization rates and per contact
transmission probability in the last four rows (in bold) in
Table 2 were obtained by least-squared curve-fitting with
the 2004-2005 Taiwan winter P&I (Pneumonia and Influ-
enza) mortality data from October 9, 2004 to March 5,
2005 for age groups 6 (age 22-64) and 7 (>64) using
MATLAB software. ν7(τ)a n dν1(τ) are piecewise linear (by
week) approximations of the respective weekly vaccination
data for elderly (>64) and young children in Taiwan during
this time period. To simply our data fitting, we first fitted
the data by assuming the per contact transmission prob-
ability of the infectees in i
th group are averaged, i.e., bij ≡
bi (see next to the last row in bold in Table 2).
Results
The result of data fit is given in Fig. 3. The reason for
using only groups 6 and 7 for data fit is that the P&I
mortality data during that winter season consists mostly
of older people. More precisely, 5038 (88.5%) of the
5694 individuals who died of P&I are of age 65 or older
(age group 7), 607 (10.7%) are between age 22-64 (age
group 6), followed by 17 between age 0-2 (age group 1)
and 14 between age 15-21 (age group 5). Each of other
age groups has only a handful of cases. Therefore, to
avoid large errors due to fitting data with small data
s i z e ,w eo n l yu s et h ed a t af r o mt h et w ol a r g e s tg r o u p s
for our model fit.
We also fitted the data by assuming the per contact
transmission probability of the infectors in i
th group are
averaged, i.e., bij ≡ bj (see the last row in bold in Table
2 and Fig. 4). We will compare these results to ascertain
the difference in age groups on per contact transmission
probabilities to and from particular age groups. To give
more insight to the data used and the goodness of fit,
we also provide the daily observed and predicated mor-
tality corresponding to the case bij ≡ bj in [Additional
file 1: Figs. S1-S2].
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Age-specific Transmission
By fitting only the hospitalization rates and the per con-
tact transmission probabilities to the 2004-2005 Taiwan
winter season P&I mortality for age groups 6 (age 22-64)
and 7 (>64), we are able to obtain satisfactory model fit
(see Fig. 3), although we note that fitting P&I deaths
might conceivably lead to an overestimate of hospitaliza-
tions rates. However, simulation studies showed that the
model fit is less sensitive to the hospitalization rates than
to the transmission probabilities, and intuitively, most
sensitive to changes in these rates for the elderly group.
It is interesting to note that comparatively significant
errors in both theoretical curves occur in late January
r o u g h l ya f t e rd a y1 1 0 .W en o t et h a td a y1 0 5w a sJ a n u -
ary 22, 2005, when all schools in Taiwan closed for the
winter vacation which lasted until after the traditional
lunar New Year holiday, in mid-February of that year.
The school closure, and subsequent shutdown of all
non-essential venues during the week-long New Year
holiday, surely had a significant impact on the contact
rates which was not reflected in our constant contact
matrix that implicitly assumes that inter-age group
contact patterns remain the same during the whole
season. More precisely, the P&I deaths for the elderly
exhibits a slight increase for about 3 weeks after the
closing of schools (shortly after the New Year) when
compared to the model predicted values, while the P&I
deaths for the adults of age 22-64 dropped substan-
tially below the theoretical curve. These results indi-
cate that the school closure and the subsequent New
Year holiday led to more frequent contacts by the
elderly in the households with family members who
s p e n tm o r et i m ea th o m ed u r i n gt h eh o l i d a y sA tt h e
same time, there were less contacts for the adults at
the workplace (especially for those working in the edu-
cational facilities who had longer holidays) during this
time period. Since most individuals in the elder group
(and the very young) are not directly affected by the
school closings and the holidays, one may speculate
that the difference in the actual mortality and the
theoretical mortality of the elderly, as averaged over
the whole time period, is due at least in parts to the
impact of interaction between the elderly and younger
children with the school-age children and adults, when
the activity levels (in terms of frequency as well as
whom to make contact with) of the latter groups were
significantly changed by the holidays.
Figure 3 Model fit for the 2004-2005 (10/9/04-3/5/05) winter cumulative P&I mortality data in Taiwan for age groups 6 (age 22-64)
and 7 (>64), with bij = bi. The black dots are the real data; the solid curves are simulated D6(t) and D7(t) from the model, where R
2 are 0.97222
and 0.99123 for fitting D6(t) and D7(t), respectively.
Hsieh BMC Infectious Diseases 2010, 10:106
http://www.biomedcentral.com/1471-2334/10/106
Page 7 of 12Furthermore, the elderly had a higher per contact
transmission probability (Table 2) but lower contact fre-
quency [Additional file 1: Table A2]. This study showed
that, with the combination of these two factors, morbid-
ity-based vaccination strategy still could be effective for
the prevention of elderly mortality. Although a recent
study to quantify the effect of school closures during the
2008 winter influenza season in Hong Kong did not find
the school closures as having a substantial effect on the
community transmission [30], our results indicate the
need for further studies on this topic. We also note that,
normally, one would like to use averaged excess winter
season P&I mortality data over other seasons for the
data fitting of seasonal influenza. However, Taiwan
often experiences summer influenza epidemics which
would offset any attempt to obtain a reasonable “excess”
P&I mortality for the winter season.
The Reproduction Number
Using Equations (2-3) we obtain R0 = 1.0001, just above
unity. However, we note that it is more appropriately
the reproduction number R of the winter flu epidemic,
given the effect of pre-epidemic immunity that must
exist. Chowell et al. [31] used several weekly seasonal flu
mortality data, derived from P&I excess deaths and
influenza-specific deaths from US, France, and Australia
during 1972-1997 (1972-2002 for US), to estimate the
(mean) reproduction number Rp over 3 decades of sea-
sonal flu. They found that the mean of Rp to be around
1.3, with year-to-year variability of 0.9-2.1. Our estimate
is lower, but within their range.
Vaccination
It is also interesting to note that for our set of para-
meter values used in Figs. 4, 5, the effective reproduc-
tion number with vaccine only (see Equations 5-6) has
almost the same value as R0, to the fourth decimal
digit. One explanation for this apparent lack of impact
of vaccination during the 2004-2005 flu season, as
indicated by the value of RV,i st h a tt h ev a c c i n a t i o n
data we used is only for groups 1 (age 0-2) and 7 (age
>64). In the formula for RV, or more precisely for Rij
V 0
in Equation (7), cij
2 is the daily contact frequency
between groups i and j. The contact frequencies of
groups 1 and 7 [Additional file 1: Table A2] are sub-
stantially smaller than the contact frequencies of the
other groups, with the exception of within-group con-
tacts and contact between groups 1 and 2 (age 3-5) in
daycare facilities. Therefore, the relative impact of tar-
geting these two groups for vaccination was weakened
Figure 4 Model fit for the 2004-2005 (10/9/04-3/5/05) winter cumulative P&I mortality data in Taiwan for age groups 6 (age 22-64)
and 7 (>64), with bij = bj. The black dots are the real data; the red curves are simulated D6(t) and D7(t) from the model, where R
2 are 0.99403
and 0.96763 for fitting D6(t) and D7(t), respectively.
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Page 8 of 12by their relative inactivity, thus giving further evidence
of the lack of impact of vaccinating the very young
and the very old on the overall transmissibility of the
disease in the community. However, simulation with
the same parameter values as in Fig. 3 except assuming
no vaccination in the young children and elderly age
groups, i.e., υ1(t)=υ7(t) = 0, and everything else the
same produces Fig. 5, where the result indicates that
the impact of no vaccination (red curves) would still
be significant, resulting in nearly 4-fold increase in
mortality of elderly and 2-fold increase in mortality of
adults. Therefore, the impact of vaccination on the dis-
ease incidence sometimes might not be fully revealed
i nt h ec h a n g e( o rt h el a c kt h e r e o f )i nt h ee f f e c t i v e
reproduction number with intervention but could still
be substantial, since it is a simple mathematical prop-
erty that distinctly different (next generation) matrices
may have similar eigenvalues.
Furthermore, in our simulations we had assumed vac-
cine efficacy (proportion of infection prevented) of 40%
for elderly and 70% for young children, to be in line
with current literature [8,9]. However, efficacy depends
very much on matching of the circulating strains with
vaccine strains each year, where mismatch often causes
low efficacy and might have affected our resulting data
fit. We also assumed vaccine effectiveness (proportion
of reduction in symptomatic cases) to be 60% for elderly
and 40% for young children (also see [8,9]).
The per contact transmission probability for the sus-
ceptible elderly (>64) infectees (see next to the last row
in Table 2) is estimated to be 0.155, more than three-
fold of any other age group (with the young children of
0-2 being the next highest), which may be due to the
common need for very close contact while the elderly
(or younger children of age <3) are being cared for, typi-
cally by individuals from adults of ages 22-64 in age
group 6, even though the frequency of contact might be
less than that of with other age groups. This further
highlights the high vulnerability of the elderly (or the
younger children) to exposure from other age groups,
and demonstrates the need for morbidity-based strategy
to prevent the elderly (or younger children) influenza
Figure 5 Simulation with the same model parameters as in Fig. 3, except υ1(t)=υ7(t)=0 . The black dots are real data, the red curves are
model fits in Fig. 3, and the blue curves denote simulation without vaccination.
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Page 9 of 12mortality. On the other hand, the estimated per contact
transmission probabilities for the younger (<3) and the
elderly (>64) infectors are also both higher than those of
the other groups (see the last row in Table 2), but not
s i g n i f i c a n t l ys oe x c e p tw h e nc o m p a r e dw i t ht h o s e
between ages 8-14. The higher transmission probabilities
of young children and elderly infectives could reflect,
again, the fact that contacts with these individuals are
usually of a more intimate nature, although these prob-
abilities are not as drastically different as their vulner-
ability to be infected. The less likelihood of
schoolchildren of 8-14 to infect others might also be
attributable to signs of their less intimate contacts with
others as they grow into adolescence.
To further explore this situation, we note that from
Equation (6), the partial derivatives of Rij
v with respect
to νiπi are:
∂
∂
=− − − + − =
∂
Rij
v
ii
RR R i j ii
v
ii i i ii ()
() [ ( ) ] ( )

 
0 1 2 1 1   if   ,
R Rij
v
ii
RR i j ij
v
ij j j ∂
=− − − ≠
()
() [ ( ) ] .


0 1 1   if  
We know RR ii
v
ii
0 ≤ from Equations (2) and (7). We
also know that  Î [0, 1] and νiπi for all i, j.S u b s e -
quently,
∂
∂
Rij
v
ii () 
is a nonincreasing function of νiπi for
all i, j.H o w e v e r ,s i n c eRV =( - 1 )
n+1 det R
V +1 ,w h e r e
RR
V
ij
V = () is the matrix with Rij
V its ijth element, the
effective reproduction number with vaccination only,
RV, does not necessarily decrease as the effective vacci-
nation rate νiπi increases. In other words, vaccination is
not always beneficial in reducing incidence and the
design of an effective vaccination program in multi-
group model is highly nontrivial, unlike in simple
epidemic models where there is a simple formula for
the critical vaccination coverage level necessary for
eradication (pc) [20]. In fact, it has been shown mathe-
matically by Hadeler and Castillo-Chavez [32], using a
model with a core group, that partially effective vaccina-
tion program may actually increase the total number of
cases. Explicit quantification of an optimal vaccination
policy ([33]) in a multi-group population scenario
remains to be a challenge for mathematical modelers
and is beyond the scope of this work. Moreover, the
Figure 6 Model fit with same model parameters as Fig. 3 except no asymptomatic infection by asymptomatic infectives (τ =0 ) .T h e
black dots are the real data; the red curves are the model fit, where R
2 are 0.97346 and 0.99259, respectively.
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and small children of age 2 or less) as the only interven-
tion since vaccination was the only intervention that
was implemented during the flu seasonal for which the
fitted P&I data was collected. Further simulations with
quarantine and home withdrawal also can be easily car-
ried out.
Pre-epidemic Immunity
A related issue is that of pre-epidemic immunity. Further
sensitivity analysis using pre-immunity in the range of
10%-30% has shown that the results of curve-fittings are
not sensitive to small changes in the pre-epidemic immu-
nity. One would expect that pre-epidemic immunity does
impact the outbreak, but nonetheless it is not reflected,
at least not in the reproduction numbers.
Pre-symptomatic infection and asymptomatic infection
by asymptomatic infectives were incorporated into the
proposed model. To gauge the roles these two features
of influenza might play in a seasonal influenza epidemic,
we performed the following simulations. Again using
Fig. 3 as a benchmark, we first assume no pre-sympto-
matic infection (τ = 0) with all other parameter values
unchanged (Fig. 6). Next we assume no asymptomatic
infection by asymptomatic infectives (ai = ai
V =0 )
(Fig. 7). The results indicate that pre-symptomatic infec-
tion seemed to have little effect on the model fits and
the fitted parameters; while asymptomatic infection by
asymptomatic infectives has a more pronounced impact
on the model fit for the elderly, perhaps indicating the
comparatively larger role asymptomatic infection plays
in disease transmission.
Finally, as the WHO Strategic Advisory Group of
Experts (SAGE) recently made its recommendations for
priorities in vaccination for the H1N1 pandemic in
terms of the social groups (e.g., healthcare workers
those with chronic medical conditions), health groups
(pregnant women), and age groups [34], the model also
can be used to divide population into social/health
groups. For example, to study vaccine policy for the
elderly, we could divide the elderly into those living in
households and those living in old age homes, since
they mix differently in these two distinct settings. The
model is also useful for simulations of the cost-effective-
ness of vaccine and other intervention measures, such
as prophylaxis treatment, perhaps in future work.
Figure 7 Model fit with same model parameters as Fig. 3 except no asymptomatic infection by asymptomatic infectives (ai =0 ) .T h e
black dots are the real data; the red curves are the model fit, where R
2 are 0.99472 and 0.94446, respectively.
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